Interestingly, L290P/V mutations of ERK3 that are identified in some cancers, albeit at a low frequency, cause an increase in cytosolic localization of ERK3 and enhanced ability to promote migration and invasion in lung cancer cell lines [53]. This evidence concerns the gene MAPK6 and lung cancer.